2024-2033 Acute Respiratory Distress Syndrome (ARDS) Market Outlook: Unlocking Growth Potential
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Acute Respiratory Distress Syndrome (ARDS) Market from 2024 to 2033?
The acute respiratory distress syndrome (ARDS) market has grown rapidly, from $1.17 billion in 2023 to $1.29 billion in 2024, with a CAGR of 10.6%. The growth is attributed to advancements in critical care medicine, an aging population, pulmonary rehabilitation, and multidisciplinary care teams.
The acute respiratory distress syndrome (ARDS) market is forecasted to grow rapidly, reaching $1.93 billion by 2028, at a CAGR of 10.7%. The growth is driven by global healthcare preparedness, vaccine development, infectious disease management, and patient-centered care models. Key trends include artificial lung devices, personalized ventilation strategies, lung-protective ventilation, and therapies targeting ARDS subtypes.
Claim Your Free Sample of the Global Acute Respiratory Distress Syndrome (ARDS) Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=13005&type=smp
The rising occurrence of pneumonia is expected to boost the acute respiratory distress syndrome (ARDS) market. Pneumonia infects one or both lungs, causing alveoli (air sacs) to fill with fluid or pus, increasing blood vessel permeability and fluid leakage into the alveoli, which hinders oxygen and carbon dioxide exchange and causes respiratory discomfort. According to the Centers for Disease Control and Prevention, there were 41,309 deaths due to pneumonia in the United States in 2021, with a mortality rate of 12.4 per 100,000 population. Thus, the prevalence of pneumonia propels the acute respiratory distress syndrome (ARDS) market.
1) By Type: Diagnosis, Treatment
2) By Cause: COVID-19 Disease 2019 (COVID-19), Sepsis, Inhalation Of Harmful Substances, Severe Pneumonia, Other Causes
3) By Severity: Mild, Moderate, Severe
4) By End User: Hospitals, Clinics, Ambulatory Service Centers, Other End Users
Major companies in the acute respiratory distress syndrome (ARDS) market are focusing on innovative drug and supplement development. For example, in November 2022, Zuventus Healthcare Ltd., an India-based pharmaceutical company, launched Aviptadil, a vasoactive intestinal peptide supplement to treat ARDS. Aviptadil helps improve breathing and reduces mortality by protecting lung cells and suppressing inflammatory markers like IL-6 and TNF-alpha.
Order Now for Fast Delivery of Your Acute Respiratory Distress Syndrome (ARDS) Market Report!
North America was the largest region in the gastrointestinal stromal tumor market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal stromal tumor market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Acute Respiratory Distress Syndrome (ARDS) Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the acute respiratory distress syndrome (ards) market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Acute Respiratory Distress Syndrome (ARDS) Market Include
1. Acute Respiratory Distress Syndrome (ARDS) Market Executive Summary
2. Acute Respiratory Distress Syndrome (ARDS) Market Segments
3. Acute Respiratory Distress Syndrome (ARDS) Market Size And Template Market Growth Rate
4. Key Acute Respiratory Distress Syndrome (ARDS) Market Trends
5. Major Acute Respiratory Distress Syndrome (ARDS) Market Drivers
……
25. Key Mergers And Acquisitions In The Acute Respiratory Distress Syndrome (ARDS) Market
26. Top Acute Respiratory Distress Syndrome (ARDS) Companies
27. Acute Respiratory Distress Syndrome (ARDS) Market Opportunities And Strategies
28. Acute Respiratory Distress Syndrome (ARDS) Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Respiratory Devices And Equipment Therapeutic And Diagnostic Global Market Report 2024
Respiratory Disposables Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/respiratory-disposables-global-market-report
Respiratory Devices And Equipment (Diagnostic) Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
